/Investor DB

National Institutes of Health (NIH) — 2012 Investments

3 investments dated 2012 · listed companies and verified rows first · show all

Invivosciences, Inc.invivosciences.comSep 2012 · $12.6M

InvivoSciences is a biotechnology company led by a team with deep expertise in biomedical engineering, pharmaceutical development, and biophysics, serving the pharmaceutical and biotech industries.

AI & Machine LearningBiotechDeep TechHealthtechMedical DevicesMadison, US

Ayla Annac(Co-founder & CEO)Annac(Co-founder, CEO, President & Board Member)Tetsuro Wakatsuki(Co-founder, Chief Scientific Officer, Patent Holder, Board Member & Scientific Advisory Board Member)Elliot Elson(Co-founder, Patent Holder, Chief Scientific Board Member, Board Member & Scientific Consultant)

NAVIGEN, INC.nvgn.comDec 2012 · $26.5M
Tephatepha.comMar 2012 · $2M

HealthtechLexington, US

Simon Williams(Executive Officer, Director)John Hartnett(Executive Officer)

BoardRichard B. Emmitt(Director)inEdward M. Giles(Director)Anthony J. Sinskey(Director)

Co-investorsThe Vertical GroupNovartis Venture Fund

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.